Healthcare for Men with Suicidal Thoughts: Needs Assessment (KUJK2NEEDS)

January 22, 2025 updated by: University Ghent

The aim of the current project is twofold, namely

  1. To gain insight into needs related to help-seeking among men with (previous) suicidal thoughts (STUDY 1). More specifically, this study examines help-seeking behaviour, possible barriers to seeking help and needs with regard to existing tools and health care among men who had suicidal thoughts. In other words, is there a difference in help-seeking behaviour between men and women with suicidal thoughts in the past and what factors contribute to this difference? More specifically:

    1. To what extent do men with suicidal thoughts in the past recognize their need for help, compared to women with suicidal thoughts in the past?
    2. What barriers and needs do men with suicidal thoughts in the past experience towards seeking help, compared to women with suicidal thoughts in the past?
    3. What barriers and needs do men with suicidal thoughts in the past experience to remain engaged in help, compared to women with suicidal thoughts in the past?

  2. To map out needs of healthcare providers in working with men with suicidal thoughts and/or behaviour (STUDY 2). More specifically, how do healthcare providers experience working with men who are feeling suicidal and what are their experienced barriers and needs. Two main research questions were formulated:

    1. How do health care providers experience working with men (in comparison to women or people of other genders) who are feeling suicidal?
    2. What needs and barriers do health care providers experience when working with men (in comparison to women or people of other genders) who are feeling suicidal?

Study Overview

Status

Status

Indicates the current recruitment status or the expanded access status.
Completed

Conditions

Conditions

The disease, disorder, syndrome, illness, or injury that is being studied. On ClinicalTrials.gov, conditions may also include other health-related issues, such as lifespan, quality of life, and health risks.

Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.

Detailed Description

Approximately three out of four people who die by suicide are men. Suicide is a complex phenomenon, which cannot be explained by a single factor, but rather is a result of a variety of neurobiological, psychological and social risk factors. Considering the difference in suicide risk between men and women, researchers have tried to identify risk factors specific to men, which might contribute to the increased suicide risk. Differences in help-seeking behaviour and received help have repeatedly been put forward as being one of these factors as men are less likely to seek help and have a higher drop-out rate once having started interventions. That is why in our new project we want to investigate what barriers and needs men experience with regard to existing healthcare and how healthcare can meet these needs.

This will be done in two studies among 1) people with suicidal thoughts in the past 3 years and 2) healthcare providers.

  • STUDY 1: A needs assessment among men with a history of suicidal thoughts, consisting of

    • One online needs assessment questionnaire (15-20 min.) for men, women and individuals with other gender identities (≥18y/o) who have experienced suicidal thoughts in the past three years. The questionnaire assesses help-seeking behaviour and factors that may be associated with it (i.e. barriers to help, perceived stigma, emotional openness, self-reliance, perceived need for help, needs regarding healthcare). This questionnaire will be administered to men as well as to women/people with a different gender identity in order to compare the different gender groups.
    • Six online focus groups with men, women and individuals with other gender identities (separately) (≥18y/o) who have experienced suicidal thoughts in the past three years.

  • STUDY 2: A needs assessment among healthcare providers, consisting of

    • One online needs assessment questionnaire (10-15 min.) for health care providers (i.e., general practitioners (GP's), psychiatrists, medical doctors, psychologists, psychotherapists and nurses working in healthcare) (≥18y/o) who have previously encountered men with suicidal thoughts and/or behaviour professionally. The questionnaire is used to identify their needs regarding working with men with suicidal thoughts.
    • Two online focus groups with health care provides (GP's, psychiatrists, medical doctors, psychologists, psychotherapists and nurses working in healthcare) (≥18y/o) who have previously encountered men with suicidal thoughts and/or behaviour professionally to further discuss these needs.

Study Type

Study Type

Describes the nature of a clinical study. Study types include interventional studies (also called clinical trials), observational studies (including patient registries), and expanded access.
Observational

Enrollment (Actual)

Enrollment

The number of participants in a clinical study. The "anticipated" enrollment is the target number of participants that the researchers need for the study.
500

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact

The name and contact information for the person who can answer enrollment questions for a clinical study. Each location where the study is being conducted may also have a specific contact, who may be better able to answer those questions.

Study Contact Backup

Study Locations

  • Belgium
      • Ghent, Belgium, 9000
        • Flemish Centre of Expertise in Suicide Prevention, Ghent University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Eligibility Criteria

The key requirements that people who want to participate in a clinical study must meet or the characteristics they must have. Eligibility criteria consist of both inclusion criteria (which are required for a person to participate in the study) and exclusion criteria (which prevent a person from participating). Types of eligibility criteria include whether a study accepts healthy volunteers, has age or age group requirements, or is limited by sex.

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

STUDY 1: adults with suicidal ideation in the past 3 years STUDY 2: healthcare providers working with men with suicidal ideation

Description

STUDY 1:

Inclusion Criteria:

  • Adults (≥18y/o)
  • Experienced suicidal thoughts in the past three year
  • Access to internet

Exclusion Criteria:

/

STUDY 2:

Inclusion Criteria:

  • Healthcare providers (eg GP's, psychiatrists, medical doctors, psychologists, psychotherapists, and nurses working in healthcare) (≥18y/o)
  • Previously encountered men with suicidal thoughts and/or behaviour professionally

Exclusion Criteria:

/

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort

Group / Cohort

A group or subgroup of participants in an observational study that is assessed for biomedical or health outcomes.
Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.
Healthcare providers (Questionnaire)

Anticipated n=360

  • Healthcare providers (eg GP's, psychiatrists, medical doctors, psychologists, psychotherapists, and nurses working in healthcare) (≥18y/o)
  • Previously encountered men with suicidal thoughts and/or behaviour professionally administered a one time online questionnaire (10-15 min.)
Other: No intervention
Observational one-time questionnaire study without intervention
Healthcare providers (Focus group)

Anticipated n=20

  • Healthcare providers (eg GP's, psychiatrists, medical doctors, psychologists, psychotherapists, and nurses working in healthcare) (≥18y/o)
  • Previously encountered men with suicidal thoughts and/or behaviour professionally administered a one time online questionnaire (10-15 min.) and optionally partake in an online focus group (2h)
Other: No intervention
Observational one-time questionnaire study without intervention
Individuals with suicidal thoughts (Questionnaire)

Anticipated n=274

  • Adults (≥18y/o)
  • Experienced suicidal thoughts in the past three year
  • Access to internet administered a one time online questionnaire (15-20 min.)
Other: No intervention
Observational one-time questionnaire study without intervention
Individuals with suicidal thoughts (Focus Group)

Anticipated n=60

  • Adults (≥18y/o)
  • Experienced suicidal thoughts in the past three year
  • Access to internet administered a one time online background questionnaire (5-10min.) and partake in a focus group (2h)
Other: No intervention
Observational one-time questionnaire study without intervention

What is the study measuring?

Primary Outcome Measures

Primary Outcome Measures

In a clinical study's protocol, the planned outcome measure that is the most important for evaluating the effect of an intervention/treatment. Most clinical studies have one primary outcome measure, but some have more than one.
Outcome Measure
Measure Description
Time Frame
STUDY 1: Help-seeking behavior
Time Frame: Baseline. Completing the questionnaire will take about 15-20 minutes
Actual help-seeking questionnaire (Rickwood ea, 2005); adapted based on study Tang ea 2023. 9 items to be rated if consulted [yes/no/not applicable] for suicidal thoughts and satisfaction with received support/advice [very dissatisfied, rather dissatisfied, neutral, rather satisfied, very satisfied]
Baseline. Completing the questionnaire will take about 15-20 minutes
STUDY 1: Experienced need
Time Frame: Baseline. Completing the questionnaire will take about 15-20 minutes
Single item from study Tang et al., 2022 [on a scale from 0-10]
Baseline. Completing the questionnaire will take about 15-20 minutes
STUDY 1: Emotional Openness
Time Frame: Baseline. Completing the questionnaire will take about 15-20 minutes
Self-developed question need/possibility for openness about suicidal thoughts [no need; insufficient opportunity; moderate opportunity; sufficient opportunity; more than sufficient opportunity] 12-item Distress Disclosure Index (Kahn & Hessling, 2001): 12 items to be rated on a 5-point Likert scale [strongly disagree to strongly agree]
Baseline. Completing the questionnaire will take about 15-20 minutes
STUDY 1: Barriers
Time Frame: Baseline. Completing the questionnaire will take about 15-20 minutes
Barriers to Access to Care Evaluation (BACE; Clement ea, 2012): 30 items to be rated on a 4-point Likert scale ([not at al, a little, quite a lot, a lot]
Baseline. Completing the questionnaire will take about 15-20 minutes
STUDY 1: Self-reliance
Time Frame: Baseline. Completing the questionnaire will take about 15-20 minutes
CMNI self-reliance factor (Mahalik ea, 2003; Levant ea, 2020): 5 items to be rated on a 4-point Likert scale [strongly disagree, disagree, agree, strongly agree]
Baseline. Completing the questionnaire will take about 15-20 minutes
STUDY 1: Stigma
Time Frame: Baseline. Completing the questionnaire will take about 15-20 minutes
Self Stigma Scale for Seeking Help (Vogel ea 2006): 10 items to be rated on a 5-point Likert scale [strongly disagree to strongly agree]
Baseline. Completing the questionnaire will take about 15-20 minutes
STUDY 1: needs of individuals with suicidal ideation
Time Frame: Baseline. Completing the questionnaire will take about 15-20 minutes
Needs: 13 needs which they can indicate whether they didn't/don't need, need(ed) but didn't receive or need(ed) and receive(d). Follow-up questions on needed information, needed professional support and needed social contact.
Baseline. Completing the questionnaire will take about 15-20 minutes
STUDY 2: needs of healthcare providers
Time Frame: Baseline. Completing the questionnaire will take about 10-15 minutes
self-developed questionnaire: experienced differences in working with men/women with suicidal thoughts [open question; 1 item on general differences on 5-point likert scale; 15 statements of aspects of care with 5-point scale to indicate differences]; needed support in working with suicidal men [open]; need for training [yes/no]; preferred format for training [webinar, e-learning, folder, information on website, study day, physical class, other]; maximum time to be invested in training [<15 minutes, 15-30 minutes, 30 minutes - 1 hour; 1-2 hours; half a day; an entire day; multiple days]; needed information [open]; conditions to partake in training [open]; where do healthcare providers expect to find information on this subject [suicide prevention websites, websites of professional associations, other]; other needs [open]; knowledge of existing tools, trainings and websites [yes/no]; use of existing websites [yes/no]
Baseline. Completing the questionnaire will take about 10-15 minutes

Other Outcome Measures

Other Outcome Measures

For clinical trials, a planned measurement described in the protocol that is used to determine the effect of an intervention/treatment on participants. For observational studies, a measurement or observation that is used to describe patterns of diseases or traits, or associations with exposures, risk factors, or treatment. Types of outcome measures include primary outcome measure and secondary outcome measure.
Outcome Measure
Measure Description
Time Frame
STUDY 1: Socio-demographic characteristics
Time Frame: Baseline. Completing the questionnaire will take about 5-10 minutes
Self-developed: gender [male, female, non-binary, other], age [open], sexual orientation [heterosexual, homosexual, bisexual, asexual, other, prefer not to say, don't know], relationship status [single, in relationship, married/cohabitant, separated, divorced, widowed], location[province and urban/rural], cultural background [Belgian background, Western migration background, non-Western migration background, other], living situation [alone, with partner, with children, with parents, with others, other - multiple options possible], education [no degree, primary education, secondary education, higher education non-university, higher education university] and employment status [student, mainly employed, mainly self-employed, mainly houseman/wife; looking for work, incapacitated, retired].
Baseline. Completing the questionnaire will take about 5-10 minutes
STUDY 1: Suicidality
Time Frame: Baseline. Completing the questionnaire will take about 15-20 minutes
Based on Gezondheidenquete 2018: suicidal ideation ever, in the past 12 months and current [yes/no]; suicide attempt ever [1/more than 1/no], in the past 12months
Baseline. Completing the questionnaire will take about 15-20 minutes
STUDY 2: socio-demographic variables
Time Frame: Baseline. Completing the questionnaire will take about 10-15 minutes
Self-developed questionnaire: gender [male, female, non-binary, other], age [open], job [GP, psychiatrist, psychologist, psychotherapist, social worker, pedagogue, psychosocial prevention advisor, nurse, other], additional psychotherapy education [yes/no], current employment [private practice, group practice, 'center for general wellbeing', 'center for mental health', psychiatric hospital, psychiatric department of a general hospital, psychiatric center, company, other], location of current employment [province], work experience [<2 years, 2-5 years, 5-10 years, 10-20 years, >20 years]
Baseline. Completing the questionnaire will take about 10-15 minutes
STUDY 2: Professional experience with men with suicidal thoughts
Time Frame: Baseline. Completing the questionnaire will take about 10-15 minutes
Professional experience with men with suicidal thoughts [never/rarely, a few times a year, monthly, weekly, daily], subjective experience [very inexperienced, rather inexperienced, a little inexperienced, rather experienced, very experienced], previous suicide attempt of a male patient [yes/no], previous passing a a male patient due to suicide [yes/no]; age group given care to [toddlers and preschoolers, children 6+, youth 14+, adults, elderly 65+ - multiple options possible], format of care provided [individual conversation, family conversation, group conversation; medication; psychotherapeutic support, psychosocial support - multiple options possible]; settings of provided care [work, school, leisure, healthcare, other - multiple options possible]
Baseline. Completing the questionnaire will take about 10-15 minutes

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Sponsor

The organization or person who initiates the study and who has authority and control over the study.
University Ghent

Investigators

Investigators

A researcher involved in a clinical study. Related terms include site principal investigator, site sub-investigator, study chair, study director, and study principal investigator.
  • Principal Investigator: Gwendolyn Portzky, PhD, University Ghent

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

Study Start

The actual date on which the first participant was enrolled in a clinical study. The "anticipated" study start date is the date that the researchers think will be the study start date.
April 25, 2024

Primary Completion (Actual)

Primary Completion

The date on which the last participant in a clinical study was examined or received an intervention to collect final data for the primary outcome measure. Whether the clinical study ended according to the protocol or was terminated does not affect this date. For clinical studies with more than one primary outcome measure with different completion dates, this term refers to the date on which data collection is completed for all the primary outcome measures. The "anticipated" primary completion date is the date that the researchers think will be the primary completion date for the study.
September 24, 2024

Study Completion (Actual)

Study Completion

The date on which the last participant in a clinical study was examined or received an intervention/treatment to collect final data for the primary outcome measures, secondary outcome measures, and adverse events (that is, the last participant's last visit). The "anticipated" study completion date is the date that the researchers think will be the study completion date.
September 27, 2024

Study Registration Dates

First Submitted

First Submitted

The date on which the study sponsor or investigator first submitted a study record to ClinicalTrials.gov. There is typically a delay of a few days between the first submitted date and the record's availability on ClinicalTrials.gov (the first posted date).
April 8, 2024

First Submitted That Met QC Criteria

First Submitted That Met QC Criteria

The date on which the study sponsor or investigator first submits a study record that is consistent with National Library of Medicine (NLM) quality control (QC) review criteria. The sponsor or investigator may need to revise and submit a study record one or more times before NLM's QC review criteria are met. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
April 16, 2024

First Posted (Actual)

First Posted

The date on which the study record was first available on ClinicalTrials.gov after National Library of Medicine (NLM) quality control (QC) review has concluded. There is typically a delay of a few days between the date the study sponsor or investigator submitted the study record and the first posted date.
April 19, 2024

Study Record Updates

Last Update Posted (Actual)

Last Update Posted

The most recent date on which changes to a study record were made available on ClinicalTrials.gov. There may be a delay between when the changes were submitted to ClinicalTrials.gov by the study's sponsor or investigator (the last update submitted date) and the last update posted date.
March 25, 2025

Last Update Submitted That Met QC Criteria

Last Update Submitted That Met QC Criteria

The most recent date on which the study sponsor or investigator submitted changes to a study record that are consistent with National Library of Medicine (NLM) quality control (QC) review criteria. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
January 22, 2025

Last Verified

Last Verified

The most recent date on which the study sponsor or investigator confirmed the information about a clinical study on ClinicalTrials.gov as accurate and current. If a study with a recruitment status of recruiting; not yet recruiting; or active, not recruiting has not been confirmed within the past 2 years, the study's recruitment status is shown as unknown.
January 1, 2025

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

Other Study ID Numbers

Identifiers or ID numbers other than the NCT number that are assigned to a clinical study by the study's sponsor, funders, or others. These numbers may include unique identifiers from other trial registries and National Institutes of Health grant numbers.
  • ONZ-2024-0066

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Help-Seeking Behavior

Clinical Trials on No intervention

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Cookie Settings

We use cookies to ensure that we give you the best experience on our website. For more details carefully read our Privacy and Cookies Policy. ...>>>You can change your preferences or withdraw your consent at any time by deleting the cookies from your website or computer as described in the policy. Please accept it and choose your preferences by ticking the corresponding boxes in the "Manage Settings" section below. Please carefully read our Terms of Service before you proceed with using any part of this website.
«Manage Settings